Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Progression Therapeutics

2000 FOUNDED
PRIVATE STATUS
Early Stage VC LATEST DEAL TYPE
1 INVESTORS
Description

Developer of prognostic tests and therapies designed to focus on the treatment of primary and metastatic cancer. The company's prognostic tests and therapies are used in the development of tumor suppressor gene for in vitro and in vivo anti-tumor activities, enabling patients to get cured from cancer at affordable prices.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Laboratory Services (Healthcare)
Drug Discovery
Primary Office
  • 11 East Greenway Plaza
  • Suite 2900
  • Houston, TX 77046
  • United States

+1 (713) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Progression Therapeutics’s full profile, request a free trial.

Progression Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Progression Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
BCM Technologies Venture Capital Minority 000 0000 000000 0

Progression Therapeutics Executive Team (1)

Name Title Board
Seat
Contact
Info
Caroline Popper MD President